Since the availability of pre‐treatment tumor tissue is generally limited to exceedingly small samples from diagnostic procedures, the actual assessment of NAT‐induced effects on tumor tissue is generally restricted to comparisons between treatment‐naïve (TN) and NAT‐treated surgical resection specimens with PDAC. Here, BRD2 is linked to neoplasm.